AnaptysBio director updates stock option awards
ANAPTYSBIO director Renton Hollings reported a series of stock option adjustments tied to a corporate separation.
Rhea-AI Filing Summary
ANAPTYSBIO director Renton Hollings reported a series of stock option adjustments tied to a corporate separation. On April 20, 2026, he acquired multiple new options to buy AnaptysBio common stock and simultaneously disposed of corresponding older options back to the issuer. The footnotes explain that, following a pro rata distribution under a Separation and Distribution Agreement between AnaptysBio and First Tracks, each existing option was split into options over both companies’ shares. These are compensation and structural option changes, all held directly, and involve derivatives only rather than open-market trades in common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
20 transactions reported
Mixed
20 txns
Insider
RENTON HOLLINGS
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (right to buy) | 15,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 15,000 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 6,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 6,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 11,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 11,000 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 11,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 11,000 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 9,200 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 9,200 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 10,600 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 10,600 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 16,510 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 16,510 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | $0.00 |
| Disposition | Stock Option (right to buy) | 5,500 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 5,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 214,640 contracts (Direct)
Footnotes (3)
- F1. Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement.
- F2. The stock option is fully vested and exercisable.
- F3. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Option grant shares: 5,500 options
Option disposition shares: 5,500 options
Option grant block: 16,510 options
+4 more
7 metrics
Option grant shares
5,500 options
Grant to buy AnaptysBio common stock at $32.17, expiration 2036-01-06
Option disposition shares
5,500 options
Disposition to issuer at $43.91 exercise price, expiration 2036-01-06
Option grant block
16,510 options
Grant at $10.87 exercise price, expiration 2035-01-06 on AnaptysBio common stock
Matching disposition block
16,510 options
Disposition to issuer at $14.83 exercise price, expiration 2035-01-06
Derivative transaction count
20 transactions
All reported entries are derivative (stock option) transactions
Acquire vs dispose counts
10 acquire, 10 dispose
Transaction summary shows equal counts of option grants and dispositions
Separation agreement date
April 20, 2026
Effective date of Separation and Distribution Agreement with First Tracks
Key Terms
Separation and Distribution Agreement, pro rata distribution, stock option, vests as to 1/12, +1 more
5 terms
Separation and Distribution Agreement regulatory
"pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks"
A separation and distribution agreement is the legal plan that sets out how a company splits into two parts and how ownership of the new business is handed to shareholders. Think of it like a divorce settlement and moving checklist combined — it allocates assets, debts, tax responsibilities and short‑term services so both businesses can operate on their own. Investors care because the terms determine who bears future risks, costs and potential value when the split completes.
pro rata distribution financial
"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock"
A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.
stock option financial
"The stock option is fully vested and exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests as to 1/12 financial
"The stock option vests as to 1/12 of the total shares monthly"
disposition to issuer financial
"transaction_action": "issuer disposition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Renton Hollings Form 4 for ANAPTYSBIO (ANAB) report?
The Form 4 shows director Renton Hollings reported multiple stock option adjustments on April 20, 2026. He acquired new options and disposed of corresponding prior options to the issuer, reflecting structural changes rather than open-market trading in AnaptysBio common shares.
Why were ANAPTYSBIO options adjusted under the Separation and Distribution Agreement?
Footnotes state each existing AnaptysBio option was adjusted after a pro rata distribution under an April 20, 2026 Separation and Distribution Agreement with First Tracks. Each outstanding option became two options, one over First Tracks shares and one over AnaptysBio shares, changing Hollings’ option profile.
Did Renton Hollings buy or sell ANAPTYSBIO common stock in this Form 4?
The reported transactions all involve stock options, not open-market trades in common stock. Codes show grants or awards (acquisitions) and dispositions to the issuer, indicating compensation and structural option changes rather than direct buying or selling of AnaptysBio shares in the market.
How many derivative transactions are reported in the ANAB Form 4 for Hollings?
The transaction summary lists 20 derivative transactions, all involving stock options. There are 10 acquisitions classified as grants or awards and 10 dispositions back to the issuer, leaving the net reported buy-sell share count neutral according to the Form 4 summary data.
What are examples of option strike prices in Renton Hollings’ ANAPTYSBIO Form 4?
Examples include options to acquire 16,510 shares of AnaptysBio common stock at a $10.87 exercise price and others at $32.17 and $21.76. Matching option blocks at higher exercise prices were disposed to the issuer as part of the same adjustment process.
How do the vesting terms work for Hollings’ ANAPTYSBIO options in this filing?
A footnote explains at least one option grant vests 1/12 of the total shares monthly, starting February 6, 2026. Vesting continues until fully vested, provided Renton Hollings continues to provide service to AnaptysBio on each monthly vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
